Intrexon reported $27.07M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US $ 65.49M 4.09M
Amgen AMGN:US $ 4.42B 680M
Anika Therapeutics ANIK:US $ 43.04M 2.79M
Arrowhead Research ARWR:US $ 105.32M 4.93M
AstraZeneca AZN:LN 840.42B 39.99B
Bluebird Bio BLUE:US $ 108.92M 13.37M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Chemocentryx CCXI:US $ 43.34M 355K
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 584.8B 95.1B
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Immunogen IMGN:US $ 75.22M 14.28M
Intrexon XON:US $ 27.07M 22.84M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Macrogenics MGNX:US $ 67.82M 9.92M
Mannkind MNKD:US $ 39.35M 6.1M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Peregrine Pharmaceuticals PPHM:US $ 33.96M 3.8M
Rigel Pharmaceuticals RIGL:US $ 42.78M 212K
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Thermo Fisher Scientific TMO:US $ 8969M 28M
Veracyte VCYT:US $ 83.6M 566K
Xencor XNCR:US $ 58.18M 854K
YTE INCY:US $ 656.97M 40.27M
Ziopharm Oncology ZIOP:US $ 9.23M 148K